Status:
WITHDRAWN
Benefit of Topical Hemostatic Powder Containing Hydrophilic Polymer With Potassium Ferrate for Hemostasis Following Nail Surgery
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Nail Diseases
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to assess the efficacy and safety of topical hemostatic powder containing hydrophilic polymer with potassium ferrate for bleeding control after nail surgical procedures
Eligibility Criteria
Inclusion
- At least 18 years old
- Patients scheduled for any type of nail surgical procedure
- Willingness to participate in the study
- Ability to understand all instructions in the English language
Exclusion
- Failure to have nail surgery performed
- Likely inability to comply with the study protocol or cooperate fully with the research team
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04384679
Start Date
June 1 2022
End Date
December 1 2023
Last Update
August 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medicine
New York, New York, United States, 10021